Ephedra Warning On Labels, Ad Materials Stipulated In Two FTC Settlements
This article was originally published in The Tan Sheet
Executive Summary
USA Pharmacal Sales and Health Labs of North America must both display a prominent warning about the health risks of ephedra in any ad, promotional item or label for products containing the ingredient, according to separate 1stipulated final orders announced by the Federal Trade Commission July 1
You may also be interested in...
FTC Weight-Loss Settlements Include Over $3 Mil. In Fines, Redress
The Federal Trade Commission announced a $1.2 mil. settlement with the manufacturer, marketers and endorser of a weight-loss patch containing seaweed extract March 10
FTC Weight-Loss Settlements Include Over $3 Mil. In Fines, Redress
The Federal Trade Commission announced a $1.2 mil. settlement with the manufacturer, marketers and endorser of a weight-loss patch containing seaweed extract March 10
FTC Weight-Loss Settlements Include Over $3 Mil. In Fines, Redress
The Federal Trade Commission announced a $1.2 mil. settlement with the manufacturer, marketers and endorser of a weight-loss patch containing seaweed extract March 10